Complications Associated with the Administration of Dantrolene 1987 to 2006: A Report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States

Anesthesia & Analgesia, 04/26/2011

Complications after dantrolene are common, but rarely life threatening. Unidentified factors in the surgical environment are associated with changes in the risk of complications. Fluid management, as part of the treatment of malignant hyperthermia (MH), has an important association with the risk of complications after dantrolene administration and should be monitored closely.

Print Article Summary Cat 2 CME Report